Dieter B. Schmidt

Dieter B. Schmidt's AcademicInfluence.com Rankings

Dieter B. Schmidt

Philosophy

#8675

World Rank

#12099

Historical Rank

Logic

#5704

World Rank

#7125

Historical Rank

philosophy Degrees

Dieter B. Schmidt

Biology

#11788

World Rank

#15212

Historical Rank

Neuroscience

#1940

World Rank

#1996

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Dieter B. Schmidt's Degrees

PhD Neuroscience University of California, San Francisco
Doctorate Medicine Stanford University

Why Is Dieter B. Schmidt Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Dieter B. Schmidt's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations (1988) (829)
New avenues for anti-epileptic drug discovery and development (2013) (502)
Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma (2011) (465)
Drug Resistance in Epilepsy: Putative Neurobiologic and Clinical Mechanisms (2005) (439)
Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. (2006) (383)
Anxiety in patients with epilepsy: Systematic review and suggestions for clinical management (2005) (363)
Enzyme induction with antiepileptic drugs: Cause for concern? (2013) (288)
Drug treatment of epilepsy in adults (2014) (272)
The clinical impact of pharmacogenetics on the treatment of epilepsy (2009) (252)
Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial Seizures (1996) (237)
Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial (1993) (217)
Modern management of epilepsy: A practical approach (2008) (205)
Experimental and Clinical Evidence for Loss of Effect (Tolerance) during Prolonged Treatment with Antiepileptic Drugs (2006) (195)
Commonalities in epileptogenic processes from different acute brain insults: Do they translate? (2018) (168)
What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs? (2004) (163)
Drug treatment of epilepsy: Options and limitations (2009) (147)
Early seizure frequency and aetiology predict long-term medical outcome in childhood-onset epilepsy. (2008) (146)
Seizure Recurrence after Planned Discontinuation of Antiepileptic Drugs in Seizure‐free Patients after Epilepsy Surgery: A Review of Current Clinical Experience (2004) (145)
Reduction of Two‐Drug Therapy in Intractable Epilepsy (1983) (144)
Placebo‐corrected efficacy of modern antiepileptic drugs for refractory epilepsy: Systematic review and meta‐analysis (2010) (143)
Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis (2017) (140)
New horizons in the development of antiepileptic drugs: Innovative strategies (2006) (130)
New horizons in the development of antiepileptic drugs (2002) (126)
Long‐term seizure outcome of surgery versus no surgery for drug‐resistant partial epilepsy: A review of controlled studies (2009) (116)
Two antiepileptic drugs for intractable epilepsy with complex-partial seizures. (1982) (114)
The sz mutant hamster: A genetic model of epilepsy or of paroxysmal dystonia? (1989) (110)
Evidence-based review on the natural history of the epilepsies. (2012) (106)
Current limitations of antiepileptic drug therapy: a conference review (2003) (100)
New Developments in Antiepileptic Drug Resistance: An Integrative View (2009) (100)
Monotherapy versus Polytherapy in Epilepsy (1995) (100)
Uncontrolled epilepsy following discontinuation of antiepileptic drugs in seizure‐free patients: a review of current clinical experience (2005) (99)
The clinical impact of new antiepileptic drugs after a decade of use in epilepsy (2002) (97)
Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review (2001) (96)
Seizure clustering during drug treatment affects seizure outcome and mortality of childhood-onset epilepsy. (2008) (92)
Adverse Effects of Valproate (1984) (89)
Increase of Human Plasma GABA by Sodium Valproate (1980) (88)
Issues related to development of antiepileptogenic therapies (2013) (86)
Diphenylhydantoin, Phenobarbital, and Primidone in Saliva, Plasma, and Cerebrospinal Fluid (1975) (85)
A Risk-Benefit Assessment of Therapies for Lennox-Gastaut Syndrome (2000) (81)
New horizons in the development of antiepileptic drugs: the search for new targets. (2004) (77)
Prognosis of seizure recurrence after stopping antiepileptic drugs in seizure-free patients: A long-term population-based study of childhood-onset epilepsy (2006) (74)
The New Anticonvulsant Drugs (1994) (73)
New strategies for the identification of drugs to prevent the development or progression of epilepsy (2002) (72)
The enigma of the latent period in the development of symptomatic acquired epilepsy — Traditional view versus new concepts (2015) (68)
Clobazam for refractory focal epilepsy. A controlled trial. (1986) (57)
Utility of Free Level Monitoring of Antiepileptic Drugs (1985) (57)
Development of new treatment approaches for epilepsy: Unmet needs and opportunities (2013) (55)
Oxcarbazepine for Treatment of Partial Epilepsy: A Review and Recommendations for Clinical Use (2000) (54)
Letter: Anti-epileptic drugs and failure of oral contraceptives. (1974) (54)
Evaluation of epileptic dogs as an animal model of human epilepsy. (1985) (53)
Alternative single anticonvulsant drug therapy for refractory epilepsy (1986) (48)
Regional differences and secular trends in the incidence of epilepsy in Finland: A nationwide 23‐year registry study (2011) (47)
How effective is surgery to cure seizures in drug-resistant temporal lobe epilepsy? (2003) (45)
Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view (2001) (45)
The chance of cure following surgery for drug-resistant temporal lobe epilepsy What do we know and do we need to revise our expectations? (2004) (45)
Is antiepileptogenesis a realistic goal in clinical trials? Concerns and new horizons (2012) (44)
Predicting antiepileptic drug response in children with epilepsy (2011) (42)
Efficacy of New Antiepileptic Drugs (2011) (41)
The administration of rescue medication to children with prolonged acute convulsive seizures in the community: what happens in practice? (2013) (40)
Long‐term employment of adults with childhood‐onset epilepsy: A prospective population‐based study (2010) (38)
Tiagabine in the treatment of epilepsy — a clinical review with a guide for the prescribing physician (2000) (38)
Generalized Tonic‐Clonic Seizures in Patients with Complex‐Partial Seizures: Natural History and Prognostic Relevance (1983) (38)
Placebo and nocebo responses in drug trials of epilepsy (2015) (37)
Oxcarbazepine add-on for drug-resistant partial epilepsy. (2016) (37)
Concepts and controversies of juvenile myoclonic epilepsy: still an enigmatic epilepsy (2014) (36)
AED discontinuation may be dangerous for seizure-free patients (2011) (35)
Outcome of childhood-onset epilepsy from adolescence to adulthood: Transition issues (2017) (35)
Anti-epileptogenic Clinical Trial Designs in Epilepsy: Issues and Options (2014) (35)
Pharmacological overtreatment in epilepsy Mechanisms and management (2002) (31)
Efforts in Epilepsy Prevention in the Last 40 Years: Lessons From a Large Nationwide Study. (2016) (31)
Is incident drug-resistance of childhood-onset epilepsy reversible? A long-term follow-up study. (2012) (30)
Prognosis of chronic epilepsy with complex partial seizures. (1984) (30)
Stopping antiepileptic drugs in seizure-free patients. (2014) (30)
The influence of antiepileptic drugs on the electroencephalogram: a review of controlled clinical studies. (1982) (29)
Long-term outcome of medically treated epilepsy (2017) (29)
Myoclonus and Epilepsy in Childhood (1997) (28)
Remission in epilepsy: How long is enough? (2017) (28)
Strategies to prevent overtreatment with antiepileptic drugs in patients with epilepsy (2002) (28)
Do traditional anti-seizure drugs have a future? A review of potential anti-seizure drugs in clinical development. (2016) (27)
Progabide for refractory partial epilepsy (1986) (26)
Clobazam for Treatment of Intractable Epilepsy: A Critical Assessment (1994) (24)
Innovative Designs of Controlled Clinical Trials in Epilepsy (1993) (23)
Geriatric epilepsy: Research and clinical directions for the future (2011) (23)
Prevention of Epilepsy: Issues and Innovations (2016) (22)
Clinical features associated with placebo response in refractory focal epilepsy (2013) (22)
Long-term risks following first remission in childhood-onset epilepsy. A population-based study (2012) (21)
Are we failing to provide adequate rescue medication to children at risk of prolonged convulsive seizures in schools? (2013) (20)
Placebo‐corrected efficacy of modern nonenzyme‐inducing AEDs for refractory focal epilepsy: Systematic review and meta‐analysis (2012) (19)
Delayed time to first remission identifies poor long-term drug response of childhood-onset epilepsy: A prospective population-based study (2009) (19)
Long-term changes in the incidence of childhood epilepsy. A population study from Finland (2016) (18)
How reliable is early treatment response in predicting long-term seizure outcome? (2007) (18)
Antiepileptic drug discovery: Does mechanism of action matter? (2011) (17)
Bodyweight gain under pregabalin therapy in epilepsy: Mitigation by counseling patients? (2008) (17)
Felbamate: Successful Development of a New Compound for the Treatment of Epilepsy (1993) (16)
Stopping epilepsy treatment in seizure remission: Good or bad or both? (2017) (16)
Drug treatment strategies for epilepsy revisited: starting early or late? One drug or several drugs? (2016) (15)
Clinical conditions of long-term cure in childhood-onset epilepsy: A 45-year follow-up study (2014) (15)
The Development of Tolerance to the Anticonvulsant Effect of Phenobarbital in Mice (1980) (13)
Vagus Nerve Stimulation for the Treatment of Epilepsy (2001) (13)
Anti-epileptic drugs and failure of oral contraceptives. (Letter) (1974) (11)
Effect of antiepileptic drugs on the postictal state. A critical overview (2010) (11)
Antiepileptic drugs and the efficiency of oral contraceptives (1975) (11)
[Treatment of epileptics with the aid of antiepileptic drug blood level determinations (author's transl)]. (1977) (11)
The impact of temporal lobe surgery on cure and mortality of drug-resistant epilepsy: summary of a workshop (2003) (10)
Long‐term mortality of patients with West syndrome (2016) (10)
Adverse effects and interactions with other drugs (1999) (10)
Biperiden for treatment of somnambulism in adolescents and adults with or without epilepsy: Clinical observations (2012) (10)
Evaluation of antiepileptic drug efficacy. A review of clinical trial design. (1994) (10)
Comments on Iyadurai SJ, Chung SS. New-onset seizures in adults: Possible association with consumption of popular energy drinks. Epilepsy & Behavior 2007;10:504–508 (2014) (9)
[Recommendations for blood studies and clinical monitoring in early detection of valproate-associated liver failure. Results of a consensus conferences 9 May - 11 May 1997 in Berlin]. (1998) (9)
Antiepileptic Drugs in Clinical Development: Differentiate or Die? (2017) (8)
Outlook: The postictal state—future directions for research (2010) (8)
The administration of rescue medication to children with prolonged acute convulsive seizures in a non-hospital setting: an exploratory survey of healthcare professionals’ perspectives (2014) (7)
Vagus Nerve Stimulation, Second Edition (2002) (7)
Evaluation of a New Immunoassay for Determination of Phenytoin and Phenobarbital: Results of a European Collaborative Control Study (1977) (6)
[Pharmacotherapy of epilepsy--current problems and controversies]. (1983) (6)
Role of Liver Function Tests in Monitoring Anticonvulsant Use (1998) (6)
Does surgery prevent worsening of epilepsy? (2013) (6)
[Serum concentration of anticonvulsants. Practical guidelines for measuring and useful interpretation. Therapy Committee of the German Section of the International Epilepsy League]. (1999) (6)
Neonatal eating epilepsy: 50-year follow-up (2014) (6)
Corrigendum to “Modern management of epilepsy: A practical approach” [Epilepsy Behav 12 (2008) 501–539] (2008) (5)
Starting, Choosing, Changing, and Discontinuing Drug Treatment for Epilepsy Patients. (2016) (5)
Time to relapse after epilepsy surgery in children: AED withdrawal policies are a contributing factor. (2014) (4)
The right and the wrong with epilepsy and her science (2016) (4)
[Patients with epilepsy and anxiety disorders. Diagnosis and treatment]. (2005) (4)
A Practical Guide to When (and How) to Withdraw Antiepileptic Drugs in Seizure-Free Patients (1996) (4)
Théodore Herpin. A mid-19th century view on epilepsy. (1988) (4)
The dilemma of treating young women with generalized epilepsy with sodium valproate and how to get out of it (2015) (4)
Vagus nerve stimulation: efficacy, safety and tolerability, in patients with epilepsy (2002) (4)
Epilepsy care in Germany (1997) (3)
Adjunctive Madopar for ultrarefractory epilepsy? Preliminary observations (2013) (3)
Neurocognition in childhood epilepsy: Impact on mortality and complete seizure remission 50 years later (2018) (3)
Seizing the moment for the future: The U.S. Anticonvulsant Screening Project (2012) (3)
[How is oxcarbazepine different from carbamazpine?]. (2004) (3)
[Neurotransmitters and epilepsy. The antiepileptic effect of biogenic amines gamma-aminobutyric-acid and taurine in patients with epilepsy (author's transl)]. (1980) (3)
Proof of principle trials: exploratory open studies (2001) (3)
Book Reviews (2003) (2)
Management of epilepsy: hope and hurdles--critical reviews and clinical guidance. Introduction. (2009) (2)
Behavioural abnormalities and retention rates of anti‐epilepsy drugs during long‐term treatment of epilepsy: a clinical perspective (1995) (2)
Overrepresentation of epilepsy in children with type 1 diabetes is declining in a longitudinal population study in Finland (2019) (2)
When and how to stop antiepileptic drugs (2013) (2)
Antiepileptic drug withdrawal in seizure-free patients (2008) (2)
[Oxcarbazepine (Trileptal). An effective and well tolerated new drug as first choice in treatment of focal seizures]. (2000) (1)
WITHDRAWN: Oxcarbazepine add-on for drug-resistant partial epilepsy. (2016) (1)
One Hundred Case Studies in Epilepsy (2001) (1)
Why Epilepsia Open? (2016) (1)
Anti-epileptogenic Clinical Trial Designs in Epilepsy: Issues and Options (2014) (1)
Chapter 7 – Antiepileptic drugs (2009) (1)
Introduction (2010) (1)
Editorial note. 'Nocturnal paroxysmal dystonia related to a prerolandic dysplasia', Epilepsy Research 2001;43:1-9. (2001) (1)
The Search for New Anticonvulsants (1999) (1)
Drug-Resistant Partial Epilepsy: Clinical and Pharmacological Criteria (1987) (1)
Comparison of Gas-Chromatographic and Spectrophotometric Determinations of Phenytoin in Serum (1975) (1)
Commentary: Novel delivery approaches for antiepileptic drugs: Hope and hurdles (2009) (1)
236 Drug Treatment of Epilepsy: are Newer Drugs More Effective than Older Ones? (2010) (1)
Obituary: J. Kiffin Penry, 1929–1996 (1996) (1)
Disease Course, Outcome Measures, and Prognostic Predictors in Epilepsy: Opportunities for Improving Outcome of Drug Trials. (2016) (1)
[Drug therapy before and after surgery for epilepsy. Critical review and recommendations]. (2000) (1)
Antiepileptic Drugs (1985) (1)
Proof of efficacy trials: seizure types (2001) (1)
Common Pitfalls in Epilepsy: Case-Based Learning (2018) (1)
206 Can Long-Term Employment Outcome of Adults with Childhood- Onset Epilepsy be Predicted? Insights and Issues (2010) (1)
Common Epilepsy Pitfalls: Case-Based Learning (2018) (1)
Evaluation of Antiepileptic Drug Efficacy (1994) (1)
[Total or partial withdrawal of antiepileptic drugs]. (1987) (1)
Thank you to our Reviewers of 2017 (2018) (0)
Synopsis and Outlook (2009) (0)
Comment (2003) (0)
Editorial Board (2008) (0)
Antiepileptic drug therapy: Does mechanism of action matter? Author reply to the letter to the editor by Brodie et al. [1] (2011) (0)
Editorial Board (2007) (0)
Editorial Board (2012) (0)
Commentary to Gregoris and Shorvon, Epilepsy & Behavior, 2013; (in this issue). Any real advances in clinical epilepsy over the last decades? (2013) (0)
An interview with Carla Bentes, 2018 Epilepsia Open Prize Winner for Clinical Research (2018) (0)
Editorial Board (2007) (0)
Editorial Board (2008) (0)
Thank you to our Reviewers of 2016 (2017) (0)
Thank you to our Reviewers (2016) (0)
Editorial Board (2011) (0)
Aspects of Epilepsy and Psychiatry edited by M. Trimble and T.G. Bolwig, J. Wiley and Sons, Chichester, 1986, 256 pp., price: U.S. $42.00 (1987) (0)
Anniversary of Epilepsy & Behavior: A reviewer's perspective (2014) (0)
Editorial Board (2011) (0)
Infantile spasms: Long-term mortality of the patients (2017) (0)
Vagus nerve stimulation in the current treatment of epilepsy (2002) (0)
Commentary to Bentes et al. “Seizures, electroencephalographic abnormalities, and outcome of ischemic stroke patients” (2018) (0)
7 - Antiepileptic drugs (2008) (0)
Editorial Board (2010) (0)
Experience in Routine Clinical Practice with Pregabalin as Add-On Medication in Focal Epilepsy: An Observational Study (2009) (0)
Introduction (2003) (0)
Editorial Board & Aims and Scope (2012) (0)
Editorial Board (2008) (0)
Monotherapy and long-term treatment: efficacy onset and tolerabilityComment (2003) (0)
Seizures. Introduction. (2010) (0)
[Drug treatment of epilepsy]. (2012) (0)
Editorial Board (2011) (0)
Antiepileptic drugs and the safety of oral contraceptives. (Abstract only) (1975) (0)
Comment (2003) (0)
Editorial Board (2012) (0)
Editorial Board (2008) (0)
Editorial Board (2006) (0)
Editorial Board (2011) (0)
Editorial Board (2008) (0)
Gottfried Benn, a German poet-physician, on epilepsy in 1910-1911. (2004) (0)
Editorial Board (2006) (0)
Chairs’ introduction (2006) (0)
Editorial Board (2010) (0)
Editorial Board (2007) (0)
Editorial Board (2011) (0)
Minimizing publication bias in Epilepsia Open: Negative or confirmatory studies and preliminary reports (2016) (0)
An interview with Jiang Li, 2018 Epilepsia Open Prize Winner for Basic Science Research (2018) (0)
Editorial Board (2011) (0)
Innovative Designs of Controlled in Epilepsy Clinical Trials (1993) (0)
Bilateral Hip Fractures in a 43-Year-Old Woman with Epilepsy (2008) (0)
Editorial Board (2007) (0)
P76 – 1607 Guidelines on the management of prolonged acute convulsive seizures in out-of-hospital settings: a gap to be filled (2013) (0)
Comment (2003) (0)
Epilepsy in Children (International Review of Child Neurology Series) J. Aicardi, Raven Press, New York, 1986, 413 pp., price: U.S. $67.50 (1987) (0)
Announcing the new Epilepsia Open Prizes (2017) (0)
Editorial Board (2012) (0)
A Textbook of Clinical Neurophysiology, edited by A.M. Halliday, S.R. Butler and R. Paul, Wiley, Chichester, 1987, 730 pp., price: £ 32.50 (1987) (0)
110 puzzling cases of epilepsy (2002) (0)
Introduction (2009) (0)
[Anti-epileptic drugs and the safety of oral contraceptives]. (1975) (0)
Editorial Board (2006) (0)
Authors’ reply to the comments by Rheims et al., 2010 (2010) (0)
Editorial Board (2011) (0)
Editorial Board (2007) (0)
Adverse effects of antiepileptic drugs in children (2013) (0)
Editorial Board & Aims and Scopes (2006) (0)
New anticonvulsant drugs edited by B.S. Meldrum and R.J. Porter, John Libby, London, 1986 (1987) (0)
Comment (2003) (0)
Editorial Board (2011) (0)
Special Issue on the TASK3 Preclinical epilepsy Common Data Elements (CDEs) of the ILAE/AES Joint Translational Task Force: Peer review process, acknowledgement to reviewers, and community feedback (2018) (0)
Abstracts (2010) (0)

This paper list is powered by the following services:

Dieter B. Schmidt's Academic­Influence.com Rankings

Dieter B. Schmidt's Degrees

Why Is Dieter B. Schmidt Influential?

Dieter B. Schmidt's Published Works

Published Works

Dieter B. Schmidt's AcademicInfluence.com Rankings